A little about Playa Zipolite, The Beach of the Dead . . .

Playa Zipolite, Oaxaca, Southern Mexico, on the Pacific Ocean. A little bit about my favorite little get-away on this small world of ours.

Zipolite, a sweaty 30-minute walk west from Puerto Angel, brings you to Playa Zipolite and another world. The feeling here is 1970's - Led Zep, Marley, and scruffy gringos.

A long, long time ago, Zipolite beach was usually visited by the Zapotecans...who made it a magical place. They came to visit Zipolite to meditate, or just to rest.

Recently, this beach has begun to receive day-trippers from Puerto Angel and Puerto Escondido, giving it a more TOURISTY feel than before.

Most people come here for the novelty of the nude beach, yoga, turtles, seafood, surf, meditation, vegetarians, discos, party, to get burnt by the sun, or to see how long they can stretch their skinny budget.

I post WWW Oaxaca, Mexico, Zipolite and areas nearby information. Also general budget, backpacker, surfer, off the beaten path, Mexico and beyond, information.

REMEMBER: Everyone is welcome at Zipolite.

ivan

Monday, January 9, 2012

Playa Zicatela..Puerto Escondido Oaxaca..Diciembre 11

Omar Akram Free as a bird

Uploaded by 2581694 on Jan 7, 2012

cd - Free as a bird

Wolfmother ~ Woman

Uploaded by marzomar11 on Jan 9, 2012

Omar E.T.C. presents: Wolfmother ~ Woman

Salvia Divinorum – DEA Control over Magic in the Mint

News

1 new result for Oaxaca

DRUGS & CLINICAL TRIALS

JANUARY 9, 2012

Salvia Divinorum – DEA Control over Magic in the Mint

Salvia divinorum is a member of the mint family with known hallucinogenic properties which have been known for centuries. Historically it has been used in shaman rituals in the Oaxaca Mexico region. The psychoactive substance within salvia divinorum has been isolated and is called salvinorin A (salv A). Unlike the typical hallucinogenic drugs that act on the serotonergic system, salv A primarily acts on the kappa opioid system. The Drug Enforcement Agency (DEA) has taken a recent interest in this compound and is currently investigating whether it should be scheduled as a controlled substance. Currently thirteen states heave enacted laws regarding the use of salv A. The question on the scheduling of salv A and the synthetic isomers of the drug may produce an interesting debate.

The literature on the addictive properties is still rather sparse and replication of the existing studies would be beneficial. A preclinical study in rodents demonstrated that salv A produced a decrease in dopamine and dopamine transmission, the endogenous neurotransmitter associated with addiction, and no effect on locomotor activity (a common test for the stimulant effects of a drug). These depressive effects would seem to be contrary to the notion of salv A being an addictive drug. Furthermore, these effects may lend value to salv A and its analogs as potential pharmacotherapeutics for neuropsychiatric conditions including addiction and mood disorders.

Other studies have demonstrated the opposite effect, where low doses of salv A increase dopamine efflux, produce a conditioned place preference, and rats examined during intracerebroventricular self-administration will self-infuse the drug. The latter two tests are common preclinical assessments of the rewarding properties associated with a drug. There exists a discrepancy in the literature on whether salv A will substitute for LSD in rodent studies using drug discrimination. On such study in rodents demonstrated that salv A and LSD share similar stimulus properties which is contrary to previous reports.

Recently a controlled behavioral pharmacology investigation was conducted in humans to assess the physiological and subjective effects of salv A. It showed that salv A does not induce changes in blood pressure or heart rate although its subjective effects are similar to other hallucinogenic drugs. Given that salv A produces hallucinogenic effects similar to other known scheduled hallucinogens careful consideration needs to be given to legality of this substance.

References

Braida D, Limonta V, Capurro V, Fadda P, Rubino T, Mascia P, Zani A, Gori E, Fratta W, Parolaro D, & Sala M (2008). Involvement of kappa-opioid and endocannabinoid system on Salvinorin A-induced reward. Biological psychiatry, 63 (3), 286-92 PMID: 17920565

Carlezon WA Jr, Béguin C, DiNieri JA, Baumann MH, Richards MR, Todtenkopf MS, Rothman RB, Ma Z, Lee DY, & Cohen BM (2006). Depressive-like effects of the kappa-opioid receptor agonist salvinorin A on behavior and neurochemistry in rats. The Journal of pharmacology and experimental therapeutics, 316 (1), 440-7 PMID: 16223871

Gehrke BJ, Chefer VI, & Shippenberg TS (2008). Effects of acute and repeated administration of salvinorin A on dopamine function in the rat dorsal striatum.Psychopharmacology, 197 (3), 509-17 PMID: 18246329

Johnson, M., MacLean, K., Reissig, C., Prisinzano, T., & Griffiths, R. (2011). Human psychopharmacology and dose-effects of salvinorin A, a kappa opioid agonist hallucinogen present in the plant Salvia divinorum Drug and Alcohol Dependence, 115 (1-2), 150-155 DOI: 10.1016/j.drugalcdep.2010.11.005

Peet, M., & Baker, L. (2011). Salvinorin B derivatives, EOM-Sal B and MOM-Sal B, produce stimulus generalization in male Sprague-Dawley rats trained to discriminate salvinorin ABehavioural Pharmacology, 22 (5 and 6), 450-457 DOI: 10.1097/FBP.0b013e328349fc1b

Drug Enforcement Administration. SALVIA DIVINORUM AND SALVINORIN A (Street Names: Maria Pastora, Sage of the Seers,
Diviner’s Sage, Salvia, Sally-D, Magic Mint). December 2010.

Image via Doug Stacey / Shutterstock.

Salvia Divinorum – DEA Control over Magic in the Mint
Brain Blogger (blog)
Historically it has been used in shaman rituals in the Oaxaca Mexico region. The psychoactive substance within salvia divinorum has been isolated and is called salvinorin A (salv A). Unlike the typical hallucinogenic drugs that act on the serotonergic ...
See all stories on this topic »